SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)

BIT:1SXP Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	22.47	23.18	24.36	28.8	27.86
Short-Term Investments	3.2	3.25	1.53	1.49	-
Cash & Short-Term Investments	25.67	26.43	25.89	30.28	27.86
Cash Growth	-2.89%	2.09%	-14.51%	8.71%	49.73%
Accounts Receivable	281.1	225.45	223.7	199.05	150.94
Other Receivables	32.41	33.73	29.71	28.65	15.76
Receivables	469.49	401.27	289.69	390.26	187.13
Inventory	174.98	146.26	138.94	128.94	83.52
Prepaid Expenses	2.55	2.77	3.13	2.94	1.88
Other Current Assets	8.72	7.51	10.69	2.1	1.77
Total Current Assets	681.4	584.25	468.34	554.52	302.16
Property, Plant & Equipment	785.67	723.49	637.81	517.21	334.14
Long-Term Investments	88.5	85.06	79.07	79.83	62.26
Goodwill	28.43	29.35	29.49	30.95	29.33
Other Intangible Assets	1.26	1.12	1.45	1.92	1.72
Long-Term Deferred Tax Assets	13.04	14.33	14.83	11.75	10.11
Other Long-Term Assets	0.34	0.32	0.84	0.33	0.18
Total Assets	1,599	1,438	1,232	1,197	739.89
Accounts Payable	103.88	95.51	90.64	99.6	63.38
Accrued Expenses	44.55	42.43	52.86	46.58	39
Short-Term Debt	219.95	200.54	137.47	120.57	96.98
Current Portion of Leases	3.81	4.93	3.14	3.38	1.39
Current Income Taxes Payable	22.5	35.33	20.4	12.65	16.3
Current Unearned Revenue	26.98	24.3	20.5	14.76	8.84
Other Current Liabilities	32.18	32.45	26.14	25.49	18.32
Total Current Liabilities	453.85	435.48	351.15	323.02	244.21
Long-Term Leases	79.2	80.87	69.19	71.43	2.21
Long-Term Unearned Revenue	116.7	78.61	66.14	39.95	19.85
Pension & Post-Retirement Benefits	23.57	27.2	18.78	14.63	34.16
Long-Term Deferred Tax Liabilities	21.99	19.94	24.82	20.7	11.75
Other Long-Term Liabilities	9.58	7.32	9.57	17.73	8.3
Total Liabilities	704.9	649.42	539.65	487.46	320.48
Common Stock	150.62	150.62	150.62	-	-
Comprehensive Income & Other	741.17	636.01	539.82	707.28	417.96
Total Common Equity	891.78	786.63	690.43	707.28	417.96
Minority Interest	1.97	1.86	1.75	1.77	1.46
Shareholders' Equity	893.75	788.49	692.18	709.04	419.42
Total Liabilities & Equity	1,599	1,438	1,232	1,197	739.89
Total Debt	302.97	286.34	209.81	195.38	100.58
Net Cash (Debt)	-277.3	-259.91	-183.92	-165.09	-72.72
Net Cash Per Share	-1.84	-1.73	-1.22	-1.10	-0.48
Filing Date Shares Outstanding	150.61	150.61	150.61	150.61	150.61
Total Common Shares Outstanding	150.61	150.61	150.61	150.61	150.61
Working Capital	227.55	148.77	117.19	231.5	57.95
Book Value Per Share	5.92	5.22	4.58	4.70	2.78
Tangible Book Value	862.09	756.16	659.49	674.41	386.91
Tangible Book Value Per Share	5.72	5.02	4.38	4.48	2.57
Land	357.5	336.47	260.95	240.49	143.56
Machinery	812.35	730.55	615.67	565.37	443.39
Construction In Progress	205.07	192.49	250.62	173.47	122.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.